Clincosm LogoSign in Get a demo

hepatocellular carcinoma, radiotherapy, sorafenib

Showing 1 - 1 of 1
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma, Radiotherapy, Sorafenib Trial in Beijing (concurrent sorafenib and IMRT, followed sorafenib

Completed
  • Hepatocellular Carcinoma, Radiotherapy, Sorafenib
  • concurrent sorafenib and IMRT, followed sorafenib maintenance
  • Beijing, Beijing, China
    Bo Chen
Jun 16, 2021